Alnylam Pharmaceuticals (DUL.MU) Q1 2026 Earnings

12FebConfirmed
Q1 2026
0.69
0.79
0.88
0.97

Details

Expected EPS
0.9739004113999999
Actual EPS
0.6908827999999999
Surprise EPS
-0.28
Surprise Percent
+29.06%

Description

Alnylam Pharmaceuticals (DUL.MU) has reported earnings of 0.6908827999999999 per share for Q1 2026.

0 Comments

Share your thoughts